Comparing Atripla vs Viread
Atripla (efavirenz / emtricitabine / tenofovir disoproxil) | Viread (tenofovir disoproxil) |
|
---|
Atripla (efavirenz / emtricitabine / tenofovir disoproxil) | Viread (tenofovir disoproxil) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Occupational Exposure, HIV Infection, Nonoccupational Exposure. Atripla may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hepatitis B, HIV Infection, Nonoccupational Exposure, Occupational Exposure. Viread may also be used for purposes not listed in this medication guide. |
Related suggestions Nonoccupational Exposure
Occupational Exposure
Popular comparisons
|
|||||||
More about Atripla (efavirenz / emtricitabine / tenofovir disoproxil) | More about Viread (tenofovir disoproxil) | ||||||||
Ratings & Reviews | |||||||||
Atripla has an average rating of 9.0 out of 10 from a total of 105 ratings on Drugs.com. 90% of reviewers reported a positive effect, while 4% reported a negative effect. |
Viread has an average rating of 7.7 out of 10 from a total of 13 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 8% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Atripla side effects |
View all Viread side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Viread prices |
||||||||
Dosage Forms | |||||||||
|
|
||||||||
Brand Names | |||||||||
N/A |
N/A |
||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
55 hours |
180 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 973 drugs are known to interact with Atripla:
|
A total of 241 drugs are known to interact with Viread:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
July 12, 2006 |
October 26, 2001 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Biktarvy
Biktarvy is a complete HIV-1 treatment in a once-a-day single tablet containing three antiviral ...
Descovy
Descovy is used to treat and prevent HIV infection in adults and adolescents. When used for HIV-1 ...
Cabenuva
Cabenuva (cabotegravir and rilpivirine) injections are a long-acting HIV treatment used to keep HIV ...
Truvada
Truvada is used to prevent HIV (HIV PrEP) or treat HIV-1 infection in combination with other HIV-1 ...
Isentress
Isentress is used to treat HIV, which causes acquired immunodeficiency syndrome (AIDS). Learn about ...
Viread
Viread (tenofovir) is used to treat HIV, which causes the acquired immunodeficiency syndrome ...
Epzicom
Epzicom is used to treat HIV, which causes the acquired immunodeficiency syndrome (AIDS). Learn ...
Efavirenz
Efavirenz is used for HIV Infection, nonoccupational exposure, occupational exposure
Lamivudine
Lamivudine is used for hepatitis b, HIV Infection, nonoccupational exposure, occupational exposure
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.